Tejara Capital LTD Cardiol Therapeutics Inc. Call Options Transaction History
Tejara Capital LTD
- $272 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CRDL
# of Institutions
38Shares Held
6.55MCall Options Held
71.7KPut Options Held
0-
Mmcap International Inc. Spc Grand Cayman, E92.57MShares$4.93 Million0.7% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD1.3MShares$2.5 Million0.41% of portfolio
-
Lion Street Advisors, LLC193KShares$369,9840.13% of portfolio
-
Cambridge Investment Research Advisors, Inc.129KShares$247,1860.0% of portfolio
-
Laird Norton Trust Company, LLC100KShares$192,0000.02% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $119M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...